Idiotope-Driven T-Cell/B-Cell Collaboration-Based T-Cell Epitope Prediction Using B-Cell Receptor Repertoire Sequences in Infectious Diseases.
B-cell
T-cell epitope
anti-idiotypic antibody
antigen
idiotope-driven T-B collaboration
idiotype network
molecular mimicry
repertoire analysis
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
17 05 2023
17 05 2023
Historique:
received:
27
02
2023
revised:
11
05
2023
accepted:
15
05
2023
medline:
29
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
T-cell recognition of antigen epitopes is a crucial step for the induction of adaptive immune responses, and the identification of such T-cell epitopes is, therefore, important for understanding diverse immune responses and controlling T-cell immunity. A number of bioinformatic tools exist that predict T-cell epitopes; however, many of these methods highly rely on evaluating conventional peptide presentation by major histocompatibility complex (MHC) molecules, but they ignore epitope sequences recognized by T-cell receptor (TCR). Immunogenic determinant idiotopes are present on the variable regions of immunoglobulin molecules expressed on and secreted by B-cells. In idiotope-driven T-cell/B-cell collaboration, B-cells present the idiotopes on MHC molecules for recognition by idiotope-specific T-cells. According to the idiotype network theory formulated by Niels Jerne, such idiotopes found on anti-idiotypic antibodies exhibit molecular mimicry of antigens. Here, by combining these concepts and defining the patterns of TCR-recognized epitope motifs (TREMs), we developed a T-cell epitope prediction method that identifies T-cell epitopes derived from antigen proteins by analyzing B-cell receptor (BCR) sequences. This method allowed us to identify T-cell epitopes that contain the same TREM patterns between BCR and viral antigen sequences in two different infectious diseases caused by dengue virus and SARS-CoV-2 infection. The identified epitopes were among the T-cell epitopes detected in previous studies, and T-cell stimulatory immunogenicity was confirmed. Thus, our data support this method as a powerful tool for the discovery of T-cell epitopes from BCR sequences.
Identifiants
pubmed: 37243272
pii: v15051186
doi: 10.3390/v15051186
pmc: PMC10221809
pii:
doi:
Substances chimiques
Epitopes, T-Lymphocyte
0
Epitopes, B-Lymphocyte
0
Receptors, Antigen, T-Cell
0
Receptors, Antigen, B-Cell
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nature. 1983 Apr 14;302(5909):575-81
pubmed: 6300689
Blood. 2003 Jun 15;101(12):4930-6
pubmed: 12576325
Scand J Immunol. 2009 Dec;70(6):526-30
pubmed: 19906193
Emerg Infect Dis. 2020 Jul;26(7):1624-1626
pubmed: 32240079
Front Immunol. 2021 Sep 15;12:712488
pubmed: 34603286
Ann Immunol (Paris). 1974 Jan;125C(1-2):373-89
pubmed: 4142565
Tissue Antigens. 2012 Oct;80(4):305-16
pubmed: 22861646
J Immunol. 1990 Mar 1;144(5):1625-8
pubmed: 1689751
J Immunol. 2004 Jun 15;172(12):7476-84
pubmed: 15187126
Front Immunol. 2017 May 03;8:389
pubmed: 28515723
N Engl J Med. 2022 Jan 27;386(4):394-396
pubmed: 34818473
Nucleic Acids Res. 2021 Jan 8;49(D1):D916-D923
pubmed: 33270111
Nucleic Acids Res. 2014 Jan;42(Database issue):D660-5
pubmed: 24304891
Trop Med Health. 2022 Jan 4;50(1):3
pubmed: 34983690
Viruses. 2012 Sep;4(9):1438-76
pubmed: 23170167
Front Oncol. 2012 Dec 19;2:196
pubmed: 23267437
Annu Rev Immunol. 2020 Apr 26;38:123-145
pubmed: 32045313
BMC Genomics. 2015 Apr 18;16:318
pubmed: 25895492
Curr Microbiol. 2021 Jan;78(1):17-32
pubmed: 33231723
Nat Rev Immunol. 2014 Jun;14(6):377-91
pubmed: 24830344
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
Lupus. 1995 Dec;4(6):464-71
pubmed: 8749569
Trends Immunol. 2010 Feb;31(2):56-62
pubmed: 19962346
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Int J Environ Res Public Health. 2021 Sep 18;18(18):
pubmed: 34574767
Transl Med Commun. 2021;6(1):18
pubmed: 34458584
Front Oncol. 2012 Nov 09;2:159
pubmed: 23162790
Biomed Rep. 2020 May;12(5):244-250
pubmed: 32257187
Nat Immunol. 2023 Apr;24(4):604-611
pubmed: 36879067
Nat Rev Immunol. 2004 Apr;4(4):308-12
pubmed: 15057789
Nat Med. 2000 Jun;6(6):667-72
pubmed: 10835683
Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29
pubmed: 28472356
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Nature. 2017 Mar 30;543(7647):723-727
pubmed: 28329770
PLoS One. 2021 Sep 3;16(9):e0257016
pubmed: 34478478
Front Immunol. 2014 Oct 28;5:541
pubmed: 25389426
PLoS Comput Biol. 2012;8(3):e1002412
pubmed: 22396638
Allergy. 2020 Jul;75(7):1564-1581
pubmed: 32396996
Immunology. 2018 Jul;154(3):394-406
pubmed: 29315598
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Viral Immunol. 2010 Jun;23(3):259-84
pubmed: 20565291
Eur J Immunol. 1999 Dec;29(12):4043-52
pubmed: 10602015
FASEB J. 1993 Mar;7(5):437-44
pubmed: 8462785
Cells. 2012 Jul 25;1(3):313-24
pubmed: 24710478
Protein Sci. 2022 Jan;31(1):173-186
pubmed: 34664328
Int J Mol Sci. 2021 Mar 22;22(6):
pubmed: 33809918
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Immunol Rev. 1998 Apr;162:233-46
pubmed: 9602368
J Exp Med. 1983 Dec 1;158(6):2183-8
pubmed: 6227679
J Exp Med. 2004 Jul 5;200(1):1-11
pubmed: 15226360
Hum Vaccin Immunother. 2013 Jul;9(7):1577-86
pubmed: 23584251
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D256-61
pubmed: 15608191
Proc Natl Acad Sci U S A. 1989 Jan;86(1):282-6
pubmed: 2492101
Front Immunol. 2015 Oct 22;6:538
pubmed: 26557118
Annu Rev Immunol. 2006;24:419-66
pubmed: 16551255
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25850-25859
pubmed: 31796587
Adv Drug Deliv Rev. 2021 Apr;171:29-47
pubmed: 33465451